ArticlePDF Available

Endemic Genotypes of Candida albicans Causing Fungemia Are Frequent in the Hospital

Authors:

Abstract and Figures

Genotyping of Candida albicans strains causing candidemia can uncover the presence of endemic genotypes in the hospital. Using a highly reproducible and discriminatory microsatellite marker panel, we studied the genetic diversity of 217 C. albicans isolates from the blood cultures of 202 patients with candidemia (from January 2007 to December 2011). Each isolate represented 1 candidemia episode. Multiple episodes were defined as the isolation of C. albicans in further blood cultures taken ≥7 days after the last isolation in blood culture. Of the 202 patients, 188 had 1 episode, 13 had 2 episodes, and 1 had 3 episodes. Identical genotypes showed the same alleles for all 6 markers. The genotypes causing both episodes were identical in most patients with 2 episodes (11/13; 84.6%). In contrast, 2 different genotypes were found in the patient with 3 episodes, one causing the first and second episodes and the other causing the third episode (isolated 6 months later). We found marked genetic diversity in 174 different genotypes: 155 were unique, and 19 were endemic and formed 19 clusters (2 to 6 patients per cluster). Up to 25% of the patients were infected by endemic genotypes that infected 2 or more different patients. Some of these endemic genotypes were found in the same unit of the hospital, mainly neonatology, whereas others infected patients in different wards.
Content may be subject to copyright.
Endemic Genotypes of Candida albicans Causing Fungemia Are
Frequent in the Hospital
Pilar Escribano,
a,b,c
Marta Rodríguez-Créixems,
a,b,c
Carlos Sánchez-Carrillo,
a,b,c
Patricia Muñoz,
a,b,c,d
Emilio Bouza,
a,b,c,d
Jesús Guinea
a,b,c,d
Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain
a
;
Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Madrid, Spain
b
; CIBER de Enfermedades Respiratorias (CIBER RES CD06/06/0058), Palma de Mallorca,
Spain
c
; Microbiology Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
d
Genotyping of Candida albicans strains causing candidemia can uncover the presence of endemic genotypes in the hospital. Us-
ing a highly reproducible and discriminatory microsatellite marker panel, we studied the genetic diversity of 217 C. albicans iso-
lates from the blood cultures of 202 patients with candidemia (from January 2007 to December 2011). Each isolate represented 1
candidemia episode. Multiple episodes were defined as the isolation of C. albicans in further blood cultures taken >7 days after
the last isolation in blood culture. Of the 202 patients, 188 had 1 episode, 13 had 2 episodes, and 1 had 3 episodes. Identical geno-
types showed the same alleles for all 6 markers. The genotypes causing both episodes were identical in most patients with 2 epi-
sodes (11/13; 84.6%). In contrast, 2 different genotypes were found in the patient with 3 episodes, one causing the first and sec-
ond episodes and the other causing the third episode (isolated 6 months later). We found marked genetic diversity in 174
different genotypes: 155 were unique, and 19 were endemic and formed 19 clusters (2 to 6 patients per cluster). Up to 25% of the
patients were infected by endemic genotypes that infected 2 or more different patients. Some of these endemic genotypes were
found in the same unit of the hospital, mainly neonatology, whereas others infected patients in different wards.
Candidemia is generally a nosocomial infection, and half of all
cases are caused by Candida albicans (15). Studying the ge-
netic relationship between C. albicans causing fungemia in the
hospital can uncover the presence of endemic genotypes, which
may suggest horizontal transmission and enable us to implement
prevention measures.
However, in the absence of genotyping, the potential routes of
infection and the presence of endemic genotypes of C. albicans in
the hospital are unknown. Several procedures are used to geno-
type C. albicans (68), and microsatellites in particular have a high
discriminatory power, the ability to detect heterozygote diploid
organisms (codominance), and a high reproducibility (912).
Previous studies have shown the presence of endemic geno-
types of C. albicans causing candidemia in specific hospital units,
mostly adult and neonatal intensive care units (ICUs) (8,13,14).
However, it is unknown whether endemic genotypes can be found
in other parts of the hospital. Furthermore, the proportion of
patients infected by endemic C. albicans genotypes has been
poorly studied.
We investigated the genotypic diversity of C. albicans isolates
from patients with candidemia who were admitted to a large ter-
tiary hospital in order to determine the percentage of patients
infected by endemic genotypes and the ward of hospitalization.
(This study was presented in part at the 22nd European Con-
gress of Clinical Microbiology and Infectious Diseases [ECCMID;
P-745], London, United Kingdom, 31 March to 3 April 2012.)
MATERIALS AND METHODS
Hospital description, definition of candidemia episodes, and patients
studied. This study was carried out at a large teaching hospital that serves
a population of approximately 715,000 inhabitants in the city of Madrid,
Spain. The institution cares for all types of patients at risk of acquiring
candidemia, including patients admitted to medical and surgical ICUs,
neonates, patients with hematological malignancies, solid organ trans-
plant recipients, and patients with central venous catheters.
During the study period, blood samples for culture were obtained by
standard procedures and incubated in the automated Bactec-NR system
(Becton-Dickinson, Cockeysville, MD).
From January 2007 to December 2011, 202 patients admitted to the
hospital had 217 episodes of candidemia caused by C. albicans. An episode
of candidemia was defined as the isolation of C. albicans from a blood
culture. In the absence of a consensus for the definition of additional
episodes of candidemia, we arbitrarily defined additional episodes as the
isolation of C. albicans in further blood cultures taken 7 days after the
last isolation in the previous episode.
Identification of the isolates. Blood cultures with presumptive visu-
alization of yeasts in the Gram stain were subcultured on CHROMagar
Candida plates (CHROMagar, Paris, France) and incubated at 35°C. Iso-
lates were identified by means of the ID 32C system (bioMérieux, Marcy
l’Etoile, France). Identification of C. albicans was confirmed by amplifi-
cation and sequencing of the ITS1-5.8S-ITS2 region (15).
Genotyping procedure. We genotyped 1 C. albicans strain represent-
ing one episode per patient using a panel of 6 short tandem repeats
(STRs), as reported elsewhere (9,11,12). The sizes of the amplified frag-
ments were determined by capillary electrophoresis with a 3130xl analyzer
(Applied Biosystems, Life Technologies Corporation, Carlsbad, CA) us-
ing the GeneScan ROX marker. Electropherograms were analyzed using
GeneMapper v.4.0 software (Applied Biosystems-Life Technologies Cor-
poration, CA). A C. albicans strain was used as a control in each run to
ensure accuracy of the size and to minimize run-to-run variation.
Received 22 February 2013 Returned for modification 3 April 2013
Accepted 17 April 2013
Published ahead of print 24 April 2013
Address correspondence to Jesús Guinea, jguineaortega@yahoo.es.
Copyright © 2013, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JCM.00516-13
2118 jcm.asm.org Journal of Clinical Microbiology p. 2118 –2123 July 2013 Volume 51 Number 7
Genotypic analysis. As C. albicans is diploid and can be homozygous
or heterozygous for each marker, the allelic composition for each locus
was studied.
The parameters of genetic diversity studied for each locus were as
follows: the number of alleles per locus and the frequency of null alleles (if
a mutation occurs at the annealing site, then the marker can no longer be
used, and the allele becomes a null allele) (16); observed heterozygosity
(Ho) (direct count calculated as the number of heterozygous genotypes
over the total number of genotypes analyzed for each locus); expected
heterozygosity (He) (He 1pi
2
, where pi is the frequency of the ith
allele) (17); Wright’s fixation index [F1(Ho/He)], which shows the
relationships between Ho and He and detects an excess or deficiency of
heterozygotes (37); and, finally, the probability of identity for unrelated
individuals [PI 1pi
4
冱冱 (2pipj)
2
, where pi and pj are the fre-
quencies of the ith and jth alleles, respectively], which measures the prob-
ability that 2 randomly drawn diploid genotypes will be identical, assum-
ing observed allele frequencies and random assortment (19).
Significant deviations (P0.001) in Hardy-Weinberg equilibrium at
the individual loci were tested using the Markov chain method. The com-
putations were performed using Arlequin version 3.01 (20) and Identity
1.0 (21).
The total allelic composition was converted to binary data by scoring
the presence or absence of each allele. Data were treated as categorical, and
the genetic relationships between the genotypes were studied by con-
structing a minimum spanning tree in BioNumerics version 6.6 (Applied
Maths, St.-Martens-Latem, Belgium). Genotypes showing the same alleles
for all 6 markers were considered identical. Endemic genotypes were de-
fined as identical genotypes infecting 2 different patients. A cluster was
defined as a group of 2 patients infected by an endemic genotype.
Endemic genotypes were confirmed after running the isolates in du-
plicate. The patients involved in each cluster were geographically related if
they were admitted to the same ward. In clusters involving patients who
were not geographically related at the time of the blood sample collection,
we studied the wards where patients had been hospitalized during the
previous 2 years.
RESULTS
Distribution of episodes of candidemia. At the time of diagnosis,
the 202 patients were admitted to the medical oncology and on-
cohematology units (n21), adult postsurgical or medical ICUs
(n34), pediatric and neonatology units (n42), and other
adult units (n105). The number of episodes per year ranged
from 32 to 55; the highest numbers of episodes were found in 2007
and 2010 (Fig. 1). The number of episodes recorded in ICUs was
higher in 2007; in contrast, the highest number of episodes in
pediatric units was found in 2010.
Intra-patient genotyping. Of the 202 patients admitted to the
medical oncology and oncohematology units, 188 had 1 episode,
13 had 2 episodes, and 1 had 3 episodes. In most of the patients
with 2 episodes (11/13; 84.6%), the genotypes involved with both
episodes were identical (mean, 10 days between episodes). In the
remaining 2 patients, the second episode occurred 10 and 13 days
after the first episode, respectively. Genotypes from the first and
second episodes differed in 2 and 3 markers, respectively.
In contrast, 2 different genotypes were found in the patient
with 3 episodes, one causing the first 2 episodes (9 days between
the first and the second episodes) and the other causing the third
episode (isolated 6 months later). The genotypes differed in 4
markers.
Genetic diversity and interpatient genotyping. The parame-
ters of genetic diversity are shown in Table 1. We found high
genetic diversity among the 217 C. albicans strains studied, as
shown by the high number of alleles detected, the low frequency of
null alleles, and the high heterozygosity. Despite the high diversity,
we observed heterozygote deficiency, as shown by the positive
values of Wright’s fixation index and the statistically significant
(P0.001) departure from Hardy-Weinberg equilibrium in the
allele frequencies of the 6 loci. The probability of identity index
was 1.05 10
8
, which showed that the markers with the highest
numbers of different alleles were the most informative.
A total of 174 genotypes were found in the 217 strains studied;
the genotype distribution is shown in Fig. 2. Of the 174 genotypes,
155 were unique and infected 1 patient each; the remaining 19
were endemic and formed 19 clusters (named 1 to 19) that in-
volved 51 patients (2 to 6 patients per cluster) (Fig. 2). Clusters
were classified according to the ward of hospitalization at the time
of blood sample collection.
The patients involved in 10 of the 19 clusters (53%) were geo-
graphically related. The first group accounted for 7 of the 19 clus-
ters and involved patients admitted to the same ward at the time of
blood sample collection, mostly in the neonatology unit (Table 2).
The 5 clusters involving neonates were observed from 2008 to
2010; 3 out of the 5 clusters included patients diagnosed in 2010,
when the highest number of cases of candidemia caused by C.
albicans was found in the unit (Fig. 1). These findings suggest the
TABLE 1 Genetic diversity in the C. albicans isolates studied
STR
a
No. of
different
alleles
Frequency
of null
alleles
b
Observed
heterozygosity
c
Expected
heterozygosity
Wright’s
index
d
Probability
of identity
e
CAI 36 0.082 0.75 0.91 0.17 0.012
CAIII 8 0.008 0.65 0.67 0.02 0.139
CAVI 36 0.113 0.65 0.86 0.24 0.028
CDC3 8 0.067 0.77 0.66 0.16 0.164
HIS3 33 0.149 0.57 0.85 0.32 0.035
EF3 20 0.143 0.59 0.85 0.31 0.035
Mean 23.5 0.071 0.67 0.80 0.15 0.07
a
Short tandem repeat. Allele frequencies of the 6 loci differed significantly (P0.001)
from those expected in a population in Hardy-Weinberg equilibrium.
b
A frequency of null alleles of 0.07 was considered nonsignificant.
c
Observed and expected heterozygosities ranged from 0 (no heterozygosity) to 1
(highest heterozygosity).
d
Wright’s index indicates a deficiency of heterozygosity (positive values) or excess
heterozygosity (negative values).
e
Probability of identity values near zero indicate the highest discriminative power of
the STR.
FIG 1 Distribution of episodes of candidemia diagnosed in each year of the
study period. The distribution of patients is also shown grouped by unit of
admission at the time of diagnosis.
C. albicans Endemic Genotypes
July 2013 Volume 51 Number 7 jcm.asm.org 2119
presence of outbreaks of candidemia, as most of the patients in-
volved were in the unit at the same time (Fig. 3). The second group
accounted for 3 of the 19 clusters that involved patients who were
in different wards at the time of the blood sample collection, al-
though they had previously shared a hospital ward (Table 3).
The 27 patients in the remaining 9 clusters (47%) did not show
a geographical relationship either at the time of blood sample
collection or during the previous 2 years. The patients who were
admitted were mainly adults (Table 4).
DISCUSSION
Candidemia caused by C. albicans is generally nosocomial (5).
Although C. albicans is part of the microbiota of patients with
candidemia, the disease can also be caused by exogenous strains
acquired during a hospital stay (10,22,23). Candidemia may be
transmitted horizontally in hospitalized patients when it is caused
by exogenous strains. Genotyping of isolates allows us to under-
stand the role of nosocomial transmission of C. albicans strains in
hospitalized patients (24,25).
We observed that most patients (75%) were infected by differ-
TABLE 2 Clusters of patients admitted to the same ward at the time of
blood sample collection
Cluster
code
No. of
patients
involved Ward of admission
Date of blood
culture collection
(month/day/yr)
1 2 Neonatology 02/14/2009
02/16/2010
6 2 Digestive medicine 12/16/2007
05/06/2008
7 2 Neonatology 03/02/2010
04/15/2010
10 2 General surgery 11/25/2009
12/03/2009
15 4 Neonatology 09/21/2010
09/24/2010
10/05/2010
10/24/2010
18 3 Neonatology 08/02/2010
12/10/2010
12/16/2010
19 2 Neonatology 06/11/2008
06/12/2008
FIG 2 Minimum spanning tree showing the distribution of the 174 genotypes (circles) found in the strains studied and the number of strains belonging to the
same genotype (larger circles indicate higher numbers). The connecting lines between the circles show the similarity between the profiles: the black lines indicate
differences in only 1 marker, and the gray lines indicate differences in 2 or more markers. The numbers represent the cluster codes.
Escribano et al.
2120 jcm.asm.org Journal of Clinical Microbiology
ent genotypes, suggesting an endogenous origin, as reported by
others (26,27). However, we found that up to 25% of patients can
be infected by endemic C. albicans genotypes. Consequently, the
strains might have a common source, such as health care workers,
biomedical devices, parenteral nutrition, and the hospital envi-
ronment (13,28,29). Interestingly, only half of the patients in-
fected by endemic genotypes were or had been admitted to the
same ward at the time of blood sample collection; in these cases,
the patients were usually in the ward at the same time. Genotyping
of the strains from the patients admitted to the neonatology ward
showed that endemic genotypes persisted in the unit for up to
several months, as illustrated by the patients in clusters 1 and 18
(Fig. 3). However, several of the clusters were found in 2010
among patients who were in the unit at the same time, suggesting
the presence of an outbreak of candidemia during that period.
Of note, 13% of the patients were infected by endemic geno-
types, although we were unable to demonstrate any geographical
relationship between them. The patients were mainly adults and
had been admitted to the hospital at different times, as shown in
Table 4. Some patients in these clusters (cluster codes 2, 3, 8, 11,
and 12) were diagnosed with candidemia at similar times, thus
suggesting a common source for the isolates. A potential explana-
tion is the presence of persistent endemic genotypes adapted to
surviving in common areas of the hospital. Patients may become
infected when visiting these areas during their stay, after ingestion
of contaminated food, or even after receiving contaminated med-
ication. Another explanation might be that these genotypes occur
more frequently than others (12,30,31) and can be actively trans-
mitted from person to person, from the environment to patients,
and from health care workers to patients.
The presence of clusters involving patients who are not geo-
graphically related may be a consequence of the limitation of the
genotyping procedure. A lack of discrimination of the STR mark-
ers used was ruled out for different reasons. First, we found
marked diversity, as shown by the total probability of identity of
1.05 10
8
, which indicates that the probability of finding 2
strains with the same genotype was almost zero. Second, a clonal
nature for the population structure is suggested by the statistically
significant deviation from Hardy-Weinberg equilibrium, proba-
bly owing to heterozygote deficiency. Finally, heterozygote defi-
ciency was not due to a lack of amplification of markers, as shown
by the low frequency of null alleles. Heterozygote deficiency might
be caused by the clonal nature of the C. albicans populations (31
34), by chromosomal rearrangements such as aneuploidy (a lack
of chromosomes or presence of extra chromosomes), or by a loss
of heterozygosity as a response to antifungal stress (3537).
Our study has several limitations. We did not determine a po-
tential source of infection or route of transmission in the hospital
because we did not study isolates from the hospital environment,
from health care workers, from other anatomical sites of the pa-
FIG 3 Timeline showing length of stay (months) for the patients involved in the 5 clusters in the neonatology unit. The numbers indicate the date of blood
sample collection for each patient involved in the cluster.
TABLE 3 Clusters involving patients who were admitted to different wards at the time of diagnosis of candidemia but who had a shared ward of
admission in the previous 2 years
Cluster
code
No. of
patients
involved
Ward of admission at time
of diagnosis
Date of blood culture
collection
(month/day/yr)
Ward of hospitalization
in the previous month Month of coincidence
4 2 Pediatric ICU 04/13/2008 Pediatric hematology March 2008
Pediatric hematology 06/16/2008
9 2 General surgery 05/09/2008 General surgery May 2008
Internal medicine 06/19/2008
17 2 Internal medicine 06/28/2007 Internal medicine May 2008
Digestive medicine 05/07/2009
C. albicans Endemic Genotypes
July 2013 Volume 51 Number 7 jcm.asm.org 2121
tients with candidemia, or even from mothers who could colonize
and further infect neonates during delivery. Since strains may
have been commensal fungi in the host, transmission between
patients could be ruled out. Furthermore, we cannot exclude the
possibility that endemic genotypes are a consequence of chromo-
somal rearrangements in the isolates or homoplasy (alleles with
identical sizes but different sequences), so we must therefore ac-
cept them as an intrinsic limitation of microsatellite analysis.
In summary, we found marked genetic diversity among C. al-
bicans isolates causing candidemia. However, up to 25% of the
patients were infected by endemic genotypes detected in 2 or more
patients. Some of these endemic genotypes were found in the same
units, whereas others infected patients in different wards. Future
studies are necessary to clarify the sources and routes of transmis-
sion of endemic genotypes in hospitals.
ACKNOWLEDGMENTS
We thank Thomas O’Boyle for editing and proofreading the article.
This work was supported by grants from the Fondo de Investigación
Sanitaria (grants PI11/00167 and PI10/02868) and Santander-Universi-
dad Complutense de Madrid (GR35/10-A). P. Escribano (CD09/00230)
and J. Guinea (MS09/00055) are supported by the Fondo de Investigación
Sanitaria. Ainhoa Simon Zarate holds a grant from the Fondo de Investi-
gación Sanitaria and provides technical support in the Línea Instrumental
Secuenciación. The 3130xl genetic analyzer was partially financed by
grants from the Fondo de Investigación Sanitaria (IF01-3624 and IF08-
36173).
REFERENCES
1. Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK,
Kjaeldgaard P, Knudsen JD, Kristensen L, Moller J, Nielsen L,
Rosenvinge FS, Roder B, Schonheyder HC, Thomsen MK, Truberg K.
2011. National surveillance of fungemia in Denmark (2004 to 2009). J.
Clin. Microbiol. 49:325–334.
2. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP,
Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O. 2009.
Epidemiology, management, and risk factors for death of invasive Can-
dida infections in critical care: a multicenter, prospective, observational
study in France (2005-2006). Crit. Care Med. 37:1612–1618.
3. Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A,
Pfaller M, Steinbach WJ, Webster KM, Marr KA. 2010. Epidemiology
and outcome of invasive fungal infections in solid organ transplant recip-
ients. Transpl Infect. Dis. 12:220 –229.
4. Peman J, Canton E, Quindos G, Eraso E, Alcoba J, Guinea J, Merino P,
Ruiz-Perez-de-Pipaon MT, Perez-del-Molino L, Linares-Sicilia MJ,
Marco F, Garcia J, Rosello EM, Gomez E, Borrell N, Porras A, Yague G.
2012. Epidemiology, species distribution, and in vitro antifungal suscep-
tibility of fungaemia in a Spanish multicentre prospective survey. J. Anti-
microb. Chemother. 67:1181–1187.
5. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. 2011.
Candida bloodstream infections: comparison of species distributions and
antifungal resistance patterns in community-onset and nosocomial iso-
lates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. An-
timicrob. Agents Chemother. 55:561–566.
6. Ben Abdeljelil J, Saghrouni F, Emira N, Valentin-Gomez E, Chatti N,
Boukadida J, Ben Said M, Del Castillo Agudo L. 2011. Molecular typing
of Candida albicans isolates from patients and health care workers in a
neonatal intensive care unit. J. Appl. Microbiol. 111:1235–1249.
7. Chowdhary A, Lee-Yang W, Lasker BA, Brandt ME, Warnock DW,
Arthington-Skaggs BA. 2006. Comparison of multilocus sequence typing
and Ca3 fingerprinting for molecular subtyping epidemiologically-related
clinical isolates of Candida albicans. Med. Mycol. 44:405– 417.
8. Shin JH, Bougnoux ME, d’Enfert C, Kim SH, Moon CJ, Joo MY, Lee K,
Kim MN, Lee HS, Shin MG, Suh SP, Ryang DW. 2011. Genetic diversity
among Korean Candida albicans bloodstream isolates: assessment by mul-
tilocus sequence typing and restriction endonuclease analysis of genomic
DNA by use of BssHII. J. Clin. Microbiol. 49:2572–2577.
9. Botterel F, Desterke C, Costa C, Bretagne S. 2001. Analysis of microsat-
ellite markers of Candida albicans used for rapid typing. J. Clin. Microbiol.
39:4076 4081.
10. Costa-de-Oliveira S, Sousa I, Correia A, Sampaio P, Pais C, Rodrigues
AG, Pina-Vaz C. 2011. Genetic relatedness and antifungal susceptibility
profile of Candida albicans isolates from fungaemia patients. Med. Mycol.
49:248 –252.
11. Sampaio P, Gusmao L, Alves C, Pina-Vaz C, Amorim A, Pais C. 2003.
Highly polymorphic microsatellite for identification of Candida albicans
strains. J. Clin. Microbiol. 41:552–557.
12. Sampaio P, Gusmao L, Correia A, Alves C, Rodrigues AG, Pina-Vaz C,
Amorim A, Pais C. 2005. New microsatellite multiplex PCR for Candida
albicans strain typing reveals microevolutionary changes. J. Clin. Micro-
biol. 43:3869 –3876.
13. Asmundsdottir LR, Erlendsdottir H, Haraldsson G, Guo H, Xu J,
Gottfredsson M. 2008. Molecular epidemiology of candidemia: evidence
of clusters of smoldering nosocomial infections. Clin. Infect. Dis. 47:e17–
d24. doi:10.1086/589298.
14. Maganti H, Yamamura D, Xu J. 2011. Prevalent nosocomial clusters
among causative agents for candidemia in Hamilton, Canada. Med. My-
col. 49:530 –538.
15. White T, Bruns T, Lee S, Taylor J. 1990. Amplification and direct
sequencing of fungal ribosomal RNA genes for phylogenetics, p 315–322.
In Innis MA, Gefland DH, Sninsky JJ, White TJ (ed), PCR protocols: a
guide to methods and applications. Academic Press, San Diego, CA.
16. Brookfield JF. 1996. A simple new method for estimating null allele fre-
quency from heterozygote deficiency. Mol. Ecol. 5:453– 455.
17. Nei M. 1973. Analysis of gene diversity in subdivided populations. Proc.
Natl. Acad. Sci. U. S. A. 70:3321–3323.
TABLE 4 Clusters involving patients who were not admitted to the
same ward at the time of blood sample collection or in the previous 2
years
Cluster
code
No. of
patients
involved
Date of blood
culture collection
(month/day/yr)
Ward of admission at
time of diagnosis
2 3 7/17/2010 Angiology
11/23/2010 Neonatology
12/16/2010 Neonatology
3 6 4/26/2008 Digestive medicine
7/18/2009 Oncology
4/30/2010 Oncohematology
7/15/2010 Oncology
12/18/2010 Geriatric
8/23/2011 General surgery
5 2 3/20/2008 Pediatric ICU
3/1/2010 Major heart postsurgical
surgery unit
8 2 11/3/2008 General surgery
11/13/2008 Major heart post-surgical
surgery unit
11 4 5/9/2008 Pneumology
9/13/2008 Adult ICU
9/23/2008 Postsurgical ICU
2/24/2010 Geriatric
12 3 5/10/2007 General surgery
8/20/2007 Geriatric
2/25/2010 General surgery
13 2 12/10/2007 Digestive medicine
3/12/2008 Major heart postsurgical
surgery unit
14 3 1/3/2008 Digestive medicine
11/18/2008 Geriatric
2/10/2009 Oncology
16 2 7/7/2010 Angiology
4/20/2011 Internal medicine
Escribano et al.
2122 jcm.asm.org Journal of Clinical Microbiology
18. Wright S. 1951. The genetical structure of populations. Ann. Eugen. 15:
323–354.
19. Paetkau D, Calvert W, Stirling I, Strobeck C. 1995. Microsatellite anal-
ysis of population structure in Canadian polar bears. Mol. Ecol. 4:347–
354.
20. Excoffier L, Laval G, Schneider S. 2005. Arlequin (version 3.0): an integrated
software package for population genetics data analysis. Evol. Bioinform. On-
line 1:47–50. http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19325852/.
21. Wagner HW, Sefc KM. 1999. IDENTITY 1.0. Centre of Applied Genetics,
University of Agricultural Sciences, Vienna, Austria.
22. Pfaller MA, Lockhart SR, Pujol C, Swails-Wenger JA, Messer SA,
Edmond MB, Jones RN, Wenzel RP, Soll DR. 1998. Hospital specificity,
region specificity, and fluconazole resistance of Candida albicans blood-
stream isolates. J. Clin. Microbiol. 36:1518 –1529.
23. Shin JH, Og YG, Cho D, Kee SJ, Shin MG, Suh SP, Ryang DW. 2005.
Molecular epidemiological analysis of bloodstream isolates of Candida
albicans from a university hospital over a five-year period. J. Microbiol.
43:546 –554.
24. Dalle F, Franco N, Lopez J, Vagner O, Caillot D, Chavanet P, Cuisenier
B, Aho S, Lizard S, Bonnin A. 2000. Comparative genotyping of Candida
albicans bloodstream and nonbloodstream isolates at a polymorphic mi-
crosatellite locus. J. Clin. Microbiol. 38:4554 4559.
25. Garcia-Hermoso D, Cabaret O, Lecellier G, Desnos-Ollivier M, Hoin-
ard D, Raoux D, Costa JM, Dromer F, Bretagne S. 2007. Comparison of
microsatellite length polymorphism and multilocus sequence typing for
DNA-based typing of Candida albicans. J. Clin. Microbiol. 45:3958 –3963.
26. Eloy O, Marque S, Botterel F, Stephan F, Costa JM, Lasserre V,
Bretagne S. 2006. Uniform distribution of three Candida albicans micro-
satellite markers in two French ICU populations supports a lack of noso-
comial cross-contamination. BMC Infect. Dis. 6:162. doi:10.1186/1471
-2334-6-162
27. Stephan F, Bah MS, Desterke C, Rezaiguia-Delclaux S, Foulet F, Du-
valdestin P, Bretagne S. 2002. Molecular diversity and routes of coloni-
zation of Candida albicans in a surgical intensive care unit, as studied using
microsatellite markers. Clin. Infect. Dis. 35:1477–1483.
28. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. 2002. Increasing
incidence of candidemia: results from a 20-year nationwide study in Ice-
land. J. Clin. Microbiol. 40:3489 –3492.
29. Ben Abdeljelil J, Saghrouni F, Khammari I, Gheith S, Fathallah A, Ben
Said M, Boukadida J. 2012. Investigation of a cluster of Candida albicans
invasive candidiasis in a neonatal intensive care unit by pulsed-field gel
electrophoresis. ScientificWorldJournal 2012:138989. doi:10.1100/2012
/138989.
30. Dalle F, Dumont L, Franco N, Mesmacque D, Caillot D, Bonnin P,
Moiroux C, Vagner O, Cuisenier B, Lizard S, Bonnin A. 2003.
Genotyping of Candida albicans oral strains from healthy individuals
by polymorphic microsatellite locus analysis. J. Clin. Microbiol. 41:
2203–2205.
31. Lott TJ, Fundyga RE, Brandt ME, Harrison LH, Sofair AN, Hajjeh RA,
Warnock DW. 2003. Stability of allelic frequencies and distributions of
Candida albicans microsatellite loci from U.S. population-based surveil-
lance isolates. J. Clin. Microbiol. 41:1316 –1321.
32. Lockhart SR, Fritch JJ, Meier AS, Schroppel K, Srikantha T, Galask R,
Soll DR. 1995. Colonizing populations of Candida albicans are clonal in
origin but undergo microevolution through C1 fragment reorganization
as demonstrated by DNA fingerprinting and C1 sequencing. J. Clin. Mi-
crobiol. 33:1501–1509.
33. Mata AL, Rosa RT, Rosa EA, Goncalves RB, Hofling JF. 2000. Clonal
variability among oral Candida albicans assessed by allozyme electropho-
resis analysis. Oral Microbiol. Immunol. 15:350 –354.
34. Pujol C, Reynes J, Renaud F, Raymond M, Tibayrenc M, Ayala FJ,
Janbon F, Mallie M, Bastide JM. 1993. The yeast Candida albicans has a
clonal mode of reproduction in a population of infected human immu-
nodeficiency virus-positive patients. Proc. Natl. Acad. Sci. U. S. A. 90:
9456 –9459.
35. Bouchonville K, Forche A, Tang KE, Selmecki A, Berman J. 2009.
Aneuploid chromosomes are highly unstable during DNA transformation
of Candida albicans. Eukaryot. Cell 8:1554 –1566.
36. Forche A, Abbey D, Pisithkul T, Weinzierl MA, Ringstrom T, Bruck D,
Petersen K, Berman J. 2011. Stress alters rates and types of loss of
heterozygosity in Candida albicans. mBio 2(4):e00129 –11. doi:10.1128
/mBio.00129-11.
37. Lenardon MD, Nantel A. 2012. Rapid detection of aneuploidy following
the generation of mutants in Candida albicans. Methods Mol. Biol. 845:
41– 49.
C. albicans Endemic Genotypes
July 2013 Volume 51 Number 7 jcm.asm.org 2123
... Studying the genetic relationship between Candida spp. isolates from patients and hospital environments is important because it may uncover the presence of endemic genotypes, which suggests a common reservoir or horizontal transmission [17][18][19][20]. Microsatellite analysis has been used as one of the most common typing tools with high discriminatory power and reproducibility, as it is able to identify specific genotypes and the genetic relationship between strains. ...
... Microsatellite analysis has been used as one of the most common typing tools with high discriminatory power and reproducibility, as it is able to identify specific genotypes and the genetic relationship between strains. This typing method can, therefore, distinguish clonal clusters from genetically unrelated genotypes and has proven to be a valuable tool for supporting epidemiological investigations [14,[17][18][19][20][21][22]. To better understand hospital C. parapsilosis sensu stricto epidemiology in pediatric patients and determine whether its occurrence is associated with clonal outbreaks and emergence of fluconazole-resistant isolates in adult patients, we conducted a 5-year retrospective study of IC cases with genotypic diversity analysis, susceptibility profiling, and biofilm formation characterization of C. parapsilosis sensu stricto isolates. ...
... Genotypes showing the same alleles for all eight markers were considered identical. Endemic genotypes were defined as identical genotypes infecting ≥ 2 different patients, and a cluster was defined as a group of ≥ 2 patients infected by an endemic genotype [17]. Endemic genotypes were confirmed after running the isolates in duplicate, with the patients involved in a cluster being geographically and temporally related. ...
Article
Full-text available
Invasive candidiasis (IC) contributes to the morbidity and mortality of hospitalized patients and represents a significant burden to the healthcare system. Previous Brazilian studies have reported the presence of endemic Candida parapsilosis sensu stricto genotypes causing candidemia and clonal transmission involving fluconazole-resistant isolates. We performed a 5-year retrospective analysis of IC cases in a Brazilian tertiary pediatric hospital and conducted a molecular investigation of C. parapsilosis sensu stricto. Non-duplicate C. parapsilosis sensu stricto genotyping was performed by microsatellite analysis. Antifungal susceptibility and biofilm formation were also evaluated. A total of 123 IC episodes were identified, with an IC incidence of 1.24 cases per 1000 hospital admissions and an overall mortality of 34%. The main species were the C. parapsilosis complex (35.8%), Candida albicans (29.2%), and Candida tropicalis (21.9%). All C. parapsilosis sensu stricto were recovered from blood cultures, and 97.5% were biofilm producers. Microsatellite typing identified high genotypic diversity among the isolates. We observed that all isolates were sensitive to amphotericin B, and although one isolate was non-sensitive to fluconazole, only a silent mutation on ERG11 gene was identified. No clear evidence of clonal outbreak or emergence of fluconazole-resistant isolates was found, suggesting that multiple sources may be involved in the epidemiology of IC in children.
... Exogenous patient-to-patient transmission may represent an alternative route of infection. Genotyping may help clarify potential Candida outbreaks and transmission in hospitalized patients (Escribano et al., 2013(Escribano et al., , 2018 and clarify if certain genotypes occur in different patients-namely clusterspotentially suggesting a common isolate niche (Escribano et al., 2013;Hammarskjold et al., 2013). ...
... Exogenous patient-to-patient transmission may represent an alternative route of infection. Genotyping may help clarify potential Candida outbreaks and transmission in hospitalized patients (Escribano et al., 2013(Escribano et al., , 2018 and clarify if certain genotypes occur in different patients-namely clusterspotentially suggesting a common isolate niche (Escribano et al., 2013;Hammarskjold et al., 2013). ...
... We have previously shown different percentages of clustered isolates in Spanish and Italian hospitals, suggesting dissimilar infection control policies (Marcos-Zambrano et al., 2015). For example, campaigns to reduce the number of catheterrelated infections led to a decrease in the number of clusters (Escribano et al., 2013(Escribano et al., , 2018. However, some clusters involved patients who were either admitted to the same hospital but without a clear epidemiological link (Escribano et al., 2013(Escribano et al., , 2018 or admitted to different hospitals that in occasions were located in different countries (Marcos-Zambrano et al., 2015). ...
Article
Full-text available
The objectives of this study were to gain further insight on Candida genotype distribution and percentage of clustered isolates between hospitals and to identify potential clusters involving different hospitals and cities. We aim to genotype Candida spp. isolates causing candidemia in patients admitted to 16 hospitals in Spain, Italy, Denmark, and Brazil. Eight hundred and eighty-four isolates (Candida albicans, n = 534; C. parapsilosis, n = 282; and C. tropicalis, n = 68) were genotyped using species-specific microsatellite markers. CDC3, EF3, HIS3, CAI, CAIII, and CAVI were used for C. albicans, Ctrm1, Ctrm10, Ctrm12, Ctrm21, Ctrm24, and Ctrm28 for C. tropicalis, and CP1, CP4a, CP6, and B for C. parapsilosis. Genotypes were classified as singletons (genotype only found once) or clusters (same genotype infecting two or more patients). Clusters were defined as intra-hospital (involving patients admitted to a single hospital), intra-ward (involving patients admitted to the same hospital ward) or widespread (involving patients admitted to different hospitals). The percentage of clusters and the proportion of patients involved in clusters among species, genotypic diversity and distribution of genetic diversity were assessed. Seven hundred and twenty-three genotypes were detected, 78 (11%) being clusters, most of which (57.7%; n = 45/78) were intra-hospital clusters including intra-ward ones (42.2%; n = 19/45). The proportion of clusters was not statistically different between species, but the percentage of patients in clusters varied among hospitals. A number of genotypes (7.2%; 52/723) were widespread (found at different hospitals), comprising 66.7% (52/78) of clusters, and involved patients at hospitals in the same city (n = 21) or in different cities (n = 31). Only one C. parapsilosis cluster was a widespread genotype found in all four countries. Around 11% of C. albicans and C. parapsilosis isolates causing candidemia are clusters that may result from patient-to-patient transmission, widespread genotypes commonly found in unrelated patients, or insufficient microsatellite typing genetic discrimination.
... Endemic genotypes were defined as genotypes infecting ≥2 different patients in one hospital. A cluster was defined as a group of ≥2 patients infected by an endemic genotype (Escribano et al., 2013). ...
... By microsatellite typing, we uncovered 32 cluster cases in 10 hospitals during a period of 2 years. The timeline of cluster cases indicates that certain endemic genotypes have persisted in the hospital setting, and presumably were difficult to eradicate, consistent with previous reports (Escribano et al., 2013(Escribano et al., , 2018. Wang et al. (2016) previously reported details of a C. parapsilosis outbreak in China, where 97 isolates comprising only two clones were mainly obtained from the ICU and surgical wards. ...
Article
Full-text available
Candida parapsilosis is an important species causing invasive candidiasis (IC) in China. The present survey was a national multicenter study of the molecular epidemiology and antifungal susceptibility profiles of C. parapsilosis. Non-duplicate C. parapsilosis isolates were collected from 10 hospitals across China in the CHIF-NET program 2016–2017. Isolates were genotyped using four highly polymorphic microsatellite markers, and susceptibility profiles determined using Sensititre YeastOneTM YO10. A total of 319 C. parapsilosis from separate patients with IC were studied; 49.2, 17.9, and 10.3% isolates were from patients in surgical departments, general intensive care units (ICUs) and neonatal ICUs (NICU), respectively. C. parapsilosis showed good susceptibility to nine antifungal drugs. Microsatellite analysis identified 122 microsatellite (MT) types. Most MT types had sporadic distribution. However, we identified 32 clusters across 10 hospitals; seven clusters were caused by seven endemic genotypes involving five or more isolates in hospitals designated as H01, H02, H06, and H10. These clusters mainly affected surgical departments and ICUs, except for genotype MT42 which was seen in 22 patients from NICU (hospital H06). Of 16 fluconazole-resistant isolates, seven from hospital H02 shared the same genotype MT70, and three from hospital H04 were of genotype MT47. For 37 isolates with non-wild type MICs to 5-flucytosine, 29 were from hospital H01 (genotype MT48). Here we present the first nationwide molecular epidemiology study of C. parapsilosis in China, identified several previously unrecognized clusters, which included antifungal drug resistant isolates. These findings provide important data for control of IC in China.
... In agreement with our prior studies, we found that the percentage of clusters in rectal swabs (11.6%) was similar to that of blood cultures [14,25,26]. Interestingly, 14% of genotypes from rectal swab samples could also be detected in blood cultures. ...
Article
Full-text available
Background: Candida spp., as part of the microbiota, can colonise the gastrointestinal tract. We hypothesised that genotyping Candida spp. isolates from the gastrointestinal tract could help spot genotypes able to cause invasive infections. Materials/methods: A total of 816 isolates of C. albicans (n = 595), C. parapsilosis (n = 118), and C. tropicalis (n = 103) from rectal swabs (n = 754 patients) were studied. Genotyping was conducted using species-specific microsatellite markers. Rectal swab genotypes were compared with previously studied blood (n = 814) and intra-abdominal (n = 202) genotypes. Results: A total of 36/754 patients had the same Candida spp. isolated from blood cultures, intra-abdominal samples, or both; these patients had candidemia (n = 18), intra-abdominal candidiasis (n = 11), both clinical forms (n = 1), and non-significant isolation (n = 6). Genotypes matching the rectal swab and their blood cultures (84.2%) or their intra-abdominal samples (92.3%) were found in most of the significant patients. We detected 656 genotypes from rectal swabs, 88.4% of which were singletons and 11.6% were clusters. Of these 656 rectal swab genotypes, 94 (14.3%) were also detected in blood cultures and 34 (5.2%) in intra-abdominal samples. Of the rectal swab clusters, 62.7% were previously defined as a widespread genotype. Conclusions: Our study pinpoints the gastrointestinal tract as a potential reservoir of potentially invasive Candida spp. genotypes.
... infections (e.g., pinpointing the infection source and unraveling outbreaks) [3,4]. Some Candida genotypes, commonly referred to as clusters, have been found to cause candidaemia in different patients and could involve patients located in a single hospital ward (intra-ward clusters), patients cared for at a given hospital (intra-hospital clusters), or patients admitted to different hospitals, sometimes located in different cities (widespread clusters) [5,6]. ...
Article
Full-text available
Background: Candidaemia and invasive candidiasis are typically hospital-acquired. Genotyping isolates from patients admitted to different hospitals may be helpful in tracking clones spreading across hospitals, especially those showing antifungal resistance. Methods: We characterized Candida clusters by studying Candida isolates (C. albicans, n = 1041; C. parapsilosis, n = 354, and C. tropicalis, n = 125) from blood cultures (53.8%) and intra-abdominal samples (46.2%) collected as part of the CANDIMAD (Candida in Madrid) study in Madrid (2019-2021). Species-specific microsatellite markers were used to define the genotypes of Candida spp. found in a single patient (singleton) or several patients (cluster) from a single hospital (intra-hospital cluster) or different hospitals (widespread cluster). Results: We found 83 clusters, of which 20 were intra-hospital, 49 were widespread, and 14 were intra-hospital and widespread. Some intra-hospital clusters were first detected before the onset of the COVID-19 pandemic, but the number of clusters increased during the pandemic, especially for C. parapsilosis. The proportion of widespread clusters was significantly higher for genotypes found in both compartments than those exclusively found in either the blood cultures or intra-abdominal samples. Most C. albicans- and C. tropicalis-resistant genotypes were singleton and presented exclusively in either blood cultures or intra-abdominal samples. Fluconazole-resistant C. parapsilosis isolates belonged to intra-hospital clusters harboring either the Y132F or G458S ERG11p substitutions; the dominant genotype was also widespread. Conclusions: the number of clusters-and patients involved-increased during the COVID-19 pandemic mainly due to the emergence of fluconazole-resistant C. parapsilosis genotypes.
... The presence of clusters could suggest a common source of infection or patientto-patient transmission and cause infections in the form of outbreaks. Clusters may go unnoticed and are only unveiled by blindly genotyping consecutive isolates causing candidaemia (Escribano et al., 2013). A high number of clusters could indicate high patient-to-patient transmission in hospital wards with a high incidence of candidaemia; as a matter offact, the implementation of prevention campaigns regarding catheter-related infections in our hospital correlated with a decrease in both the number of candidaemia episodes and the number of C. albicans and C. parapsilosis clusters (Escribano et al., 2018). ...
Article
Full-text available
Candida parapsilosis is a leading cause of invasive candidiasis in southern Europe, Latin America and Asia. C. parapsilosis has been mostly considered susceptible to triazoles, but fluconazole resistance is on the rise in some countries. The main mechanism related to fluconazole resistance is the presence of ERG11p substitutions, dominated by the Y132F amino acid substitution. Isolates harbouring this substitution mimic C. auris given that they may cause hospital outbreaks, become endemic, and emerge simultaneously in distant areas around the world. At the moment, Spain is experiencing a brusque emergence of fluconazole resistance in C. parapsilosis ; isolates harbouring the Y132F substitution were detected for the first time in 2019. A recent study on Candida spp isolates from blood cultures collected in 16 hospitals located in the Madrid metropolitan area (2019 to 2021) reported that fluconazole resistance in C. parapsilosis reached as high as 13.6%. Resistance rates rose significantly during those three years: 3.8% in 2019, 5.7% in 2020, and 29.1% in 2021; resistant isolates harboured either the dominant Y132F substitution (a single clone found in four hospitals) or G458S (another clone found in a fifth hospital). The COVID-19 pandemic may have increased the number of candidaemia cases. The reason for such an increase might be a consequence of uncontrolled intra-hospital patient-to-patient transmission in some hospitals, as an increase not only in C. parapsilosis candidaemia episodes but also in the spread of clonal fluconazole-resistant isolates might have occurred in other hospitals during the pandemic period. Patients affected with fluconazole-resistant C. parapsilosis harbouring the Y132F substitution presented a mortality rate ranging from 9% to 78%, were mainly admitted to intensive care wards but did not have differential risk factors compared to those infected by susceptible isolates. With scarce exceptions, few patients (≤20%) infected with fluconazole-resistant isolates had previously received fluconazole, thus supporting the fact that, although fluconazole might have been a key factor to promote resistance, the main driver promoting the spread of fluconazole-resistant isolates was patient-to-patient transmission.
... Escribano et al. [88] studied in detail the endemic genotypes of Candida albicans causing fungemia in a large number of patients from the same hospital. These researchers found that up to 25% of patients were infected by endemic C. albicans genotypes (more than half of them being located in the same ward of the hospital), thus demonstrating that the isolates might have originated from common sources, i.e., contact with healthcare workers, the use of catheters and other biomedical devices, parenteral nutrition, or other sources in the hospital environment. ...
Article
Full-text available
This study targets on-site/real-time taxonomic identification and metabolic profiling of seven different Candida auris clades/subclades by means of Raman spectroscopy and imaging. Representative Raman spectra from different Candida auris samples were systematically deconvoluted by means of a customized machine-learning algorithm linked to a Raman database in order to decode structural differences at the molecular scale. Raman analyses of metabolites revealed clear differences in cell walls and membrane structure among clades/subclades. Such differences are key in maintaining the integrity and physical strength of the cell walls in the dynamic response to external stress and drugs. It was found that Candida cells use the glucan structure of the extracellular matrix, the degree of α-chitin crystallinity, and the concentration of hydrogen bonds between its antiparallel chains to tailor cell walls’ flexibility. Besides being an effective ploy in survivorship by providing stiff shields in the α–1,3–glucan polymorph, the α–1,3–glycosidic linkages are also water-insoluble, thus forming a rigid and hydrophobic scaffold surrounded by a matrix of pliable and hydrated β–glucans. Raman analysis revealed a variety of strategies by different clades to balance stiffness, hydrophobicity, and impermeability in their cell walls. The selected strategies lead to differences in resistance toward specific environmental stresses of cationic/osmotic, oxidative, and nitrosative origins. A statistical validation based on principal componendist analysis was found only partially capable of distinguishing among Raman spectra of clades and subclades. Raman barcoding based on an algorithm converting spectrally deconvoluted Raman sub-bands into barcodes allowed for circumventing any speciation deficiency. Empowered by barcoding bioinformatics, Raman analyses, which are fast and require no sample preparation, allow on-site speciation and real-time selection of appropriate treatments.
Article
Candida haemulonii complex species can be multidrug-resistant (MDR) and cause infections such as candidemia. This study determined the genetic relationship between isolates from Brazil and the United States through whole-genome sequencing and performed antifungal susceptibility testing to investigate drug resistance. Contrary to what is widely described, most isolates were susceptible to azoles. However, an atypical susceptibility profile was found in 50% of C. pseudohaemulonii strains including resistance to the three echinocandins. Isolates from both countries formed distinct clusters with wide genetic diversity. Isolates from three hospitals in Brazil were clonal and involved in candidemia cases, pointing to the importance of improving hospital infection control measures and molecular identification.
Article
Full-text available
The capacity of Candida spp. to form biofilms allows them to attach either to living or inert surfaces, promoting their persistence in hospital environments. In a previous study, we reported strain-to-strain variations in Candida spp. biofilm development, suggesting that some genotypes may be greater biofilm formers than others. In this study, we hypothesize that isolates pertaining to clusters may be found more frequently in the environment due to their ability to form biofilms compared to singleton genotypes. Two hundred and thirty-nine Candida spp. isolates (78 clusters) from candidemia patients admitted to 16 hospitals located in different cities and countries-and the same number of singleton genotypes used as controls-were tested in terms of biofilm formation using the crystal violet and the XTT reduction assays. Candida albicans clusters showed higher biofilm formation in comparison to singleton genotypes (P < .01). The biofilms formed by intra-hospital C. albicans clusters showed higher metabolic activity (P < .05). Furthermore, marked variability was found among species and type of cluster. We observed that the higher the number of isolates, the higher the variability of biofilm production by isolates within the cluster, suggesting that the production of biofilm by isolates of the same genotype is quite diverse and does not depend on the type of cluster studied. In conclusion, candidemia Candida spp. clusters-particularly in the case of C. albicans-show significantly more biomass production and metabolic activity than singleton genotypes.
Article
Although the epidemiology of pathogenic Candida species causing invasive human diseases is changing, Candida albicans still remains the most common cause of bloodstream infections worldwide. The propensity of this pathogen to cause infections is undoubtedly the result of its unique genetic plasticity that allow it to adapt and respond quickly to a myriad of changing conditions both in the host and in the environment. For this reason, we decided to investigate the genetic diversity of this important fungal pathogen in a particular category of patients with severe neurological deficits including the hospital environments where they are hospitalized. Genetic diversity of 21 C. albicans isolates recovered from blood, hands of healthcare workers and hospital environments was evaluated by using multilocus sequence typing (MLST) which revealed a high genetic heterogeneity with a set of 18 diploid sequence types (DSTs) recovered among 21 isolates investigated. Interestingly, 13 of these 18 MLST genotypes were completely new and added to the C. albicans MLST central database. Six eBURST clonal complexes (CC-1, CC-2, CC-6, CC-9, CC-27 and CC-42) and three singletons contained all DSTs found in this study. Among all the new DSTs identified, DST3388 was the most intriguing as this genotype was recovered from a typical C. albicans isolate clustering within the MLST-Clade 13, the most divergent evolutionary lineage within C. albicans population containing only isolates with unusual phenotypes originally known as Candida africana. In conclusion, the results of this study expand our understanding of the molecular epidemiology and global population structure of C. albicans suggesting that further studies on different categories of patients and hospital environments are needed to better understand how the population of this species adapts and evolves in heterogeneous hosts and changing environments.
Article
Full-text available
Arlequin ver 3.0 is a software package integrating several basic and advanced methods for population genetics data analysis, like the computation of standard genetic diversity indices, the estimation of allele and haplotype frequencies, tests of departure from linkage equilibrium, departure from selective neutrality and demographic equilibrium, estimation or parameters from past population expansions, and thorough analyses of population subdivision under the AMOVA framework. Arlequin 3 introduces a completely new graphical interface written in C++, a more robust semantic analysis of input files, and two new methods: a Bayesian estimation of gametic phase from multi-locus genotypes, and an estimation of the parameters of an instantaneous spatial expansion from DNA sequence polymorphism. Arlequin can handle several data types like DNA sequences, microsatellite data, or standard multilocus genotypes. A Windows version of the software is freely available on http://cmpg.unibe.ch/software/arlequin3.
Article
Full-text available
Nosocomial invasive candidiasis (IC) has emerged as a major problem in neonatal intensive care units (NICUs). We investigated herein the temporal clustering of six cases of neonatal IC due to Candida albicans in an NICU. Eighteen isolates obtained from the six neonates and two isolates from two health care workers (HCWs) working at the same unit and suffering from fingers' onychomycosis were genotyped by electrophoretic karyotyping (EK) and restriction endonuclease analysis of genomic DNA by using Sfi I (PFGE-Sfi I). PFGE-Sfi I was more effective in discriminating between temporally related isolates. It showed that (i) both HCWs had specific strains excluding them as a source of infections in neonates. (ii) Isolates collected from three neonates were identical providing evidence of their clonal origin and the occurrence of a horizontal transmission of C. albicans in the unit. (iii) The three remaining neonates had specific strains confirming that the IC cases were coincidental. (iv) Microevolution occurred in one catheter-related candidemia case. Our results illustrate the relevance of the molecular approach to investigate suspected outbreaks in hospital surveys and the effectiveness of PFGE-Sfi I for typing of epidemiologically related C. albicans isolates.
Article
Full-text available
To update the knowledge of the epidemiology of fungaemia episodes in Spain, the species implicated and their in vitro antifungal susceptibilities. Episodes were identified prospectively over 13 months at 44 hospitals. Molecular methods were used to determine the cryptic species inside the Candida parapsilosis and Candida glabrata complexes. Susceptibility to amphotericin B, anidulafungin, caspofungin, fluconazole, flucytosine, itraconazole, micafungin, posaconazole and voriconazole was determined by a microdilution colorimetric method. New species-specific clinical breakpoints (SSCBPs) for echinocandins, fluconazole and voriconazole were applied. The incidence of the 1357 fungaemia episodes evaluated was 0.92 per 1000 admissions. The incidence of Candida albicans fungaemia was the highest (0.41 episodes/1000 admissions), followed by Candida parapsilosis sensu stricto (0.22). Candida orthopsilosis was the fifth cause of fungaemia (0.02), outnumbered by Candida glabrata and Candida tropicalis. Interestingly, the incidence of fungaemia by C. parapsilosis was 11 and 74 times higher than that by C. orthopsilosis and Candida metapsilosis, respectively. Neither Candida nivariensis nor Candida bracarensis was isolated. Fungaemia was more common in non-intensive care unit settings (65.2%) and among elderly patients (46.4%), mixed fungaemia being incidental (1.5%). Overall susceptibility rates were 77.6% for itraconazole, 91.9% for fluconazole and 96.5%-99.8% for the other agents. Important resistance rates were only observed in C. glabrata for itraconazole (24.1%) and posaconazole (14.5%), and in Candida krusei for itraconazole (81.5%). Fungaemia is more common in non-critical patients. C. albicans is the most common species, followed by C. parapsilosis and C. glabrata. Nearly 90% of yeasts are susceptible to all antifungal agents tested. Resistance rates change moderately when applying the new SSCBPs.
Article
A method is presented by which the gene diversity (heterozygosity) of a subdivided population can be analyzed into its components, i.e., the gene diversities within and between subpopulations. This method is applicable to any population without regard to the number of alleles per locus, the pattern of evolutionary forces such as mutation, selection, and migration, and the reproductive method of the organism used. Measures of the absolute and relative magnitudes of gene differentiation among subpopulations are also proposed.